KIT and hepatocellular carcinoma: PreS1 increases the capacity of normal hepatocyte-derived cell line (L02) and human hepatoma cell line (HepG2 and Huh-7) to induce tumorigeneses in nude mice by activating CD133, CD117, and CD90 expression in both cell lines.